HDL Therapeutics

About:

HDL Therapeutics is a medical device company that develops cardiovascular therapeutic device designed to fight heart disease.

Website: http://hdltherapeutics.com

Description:

HDL Therapeutics have developed the first therapy of its kind to rapidly reverse coronary atherosclerosis in patients with Homozygous Familial Hypercholesterolemia (HoFH).

Total Funding Amount:

$10.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vero Beach, Florida, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)hdltherapeutics.com

Founders:

Bryan Brewer, Michael Matin

Number of Employees:

1-10

Last Funding Date:

2021-03-04

IPO Status:

Private

Industries: